microdosing semaglutide for maintenance THE GLP-1 PROGRAM Microdosing Semaglutide: Smarter Approach to
Description
A daily oral (pill) version of semaglutide, Rybelsus, was approved for type 2 diabetes treatment in 2019
The medication slows down the movement of food through the intestine and how quickly your stomach digests food
Notably, GLP-1 affects a web of signaling cascades
Like other GLP-1 medications, Retatrutide may reduce food cravings and help break unhealthy eating patterns
If you have more questions about weight loss and your diabetes treatment plan, talk with your doctor or pharmacist
In several reported cases, symptoms improved following medication discontinuation, suggesting a potential causal relationship
